Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
Marona J, Sepriano A, Rodrigues-Manica S, Pimentel-Santos F, Mourão AF, Gouveia N, Branco JC, Santos H, Vieira-Sousa E, Vinagre F, Tavares-Costa J, Rovisco J, Bernardes M, Madeira N, Cruz-Machado R, Roque R, Silva JL, Marques ML, Ferreira RM, Ramiro S.
Marona J, et al. Among authors: rovisco j.
RMD Open. 2020 Jan;6(1):e001145. doi: 10.1136/rmdopen-2019-001145.
RMD Open. 2020.
PMID: 32144137
Free PMC article.